InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
高级管理人员已披露买入
1
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the detailed record of transactions filed by Kim Dennis d, Directeur Médical. Officer active across 1 company, notably CymaBay Therapeutics, Inc.. In total, 3 filings have been published. Split: 1 buy · 0 sell. Total volume traded: €54k. Activity tracked since 19 January 2022. The latest transaction was filed on 13 April 2023 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Kim Dennis d
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报3 总计
7,781 股@ US$4.3722.2% 占其流量Common StockSEC:0001062993-23-009245:0
100 股@ US$4.370.3% 占其流量Common StockSEC:0001062993-23-008102:0
20,000 股@ US$3.0463.3% 占其流量Common StockSEC:0001062993-22-001295:0
标准退出：2022年4月19日 (T+90)
3 条申报中的 3 条
About Kim Dennis d
Dennis D. Kim is the Chief Medical Officer of CymaBay Therapeutics, Inc. He is responsible for the medical direction and clinical strategies of the company. With expertise in clinical research, he plays a key role in developing innovative treatments for rare diseases.
